GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Rightongene Biotechnology Co Ltd (SHSE:688217) » Definitions » Valuation Rank

Shanghai Rightongene Biotechnology Co (SHSE:688217) Valuation Rank


View and export this data going back to 2021. Start your Free Trial

What is Shanghai Rightongene Biotechnology Co Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.


Shanghai Rightongene Biotechnology Co Valuation Rank Related Terms

Thank you for viewing the detailed overview of Shanghai Rightongene Biotechnology Co's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Rightongene Biotechnology Co Business Description

Traded in Other Exchanges
N/A
Address
No. 6055, Jinhai Road, Building 3, Fengxian District, Shanghai, CHN, 201499
Shanghai Rightongene Biotechnology Co Ltd is engaged in the research and development, production, sales, scientific research and testing services of in vitro diagnostic products.
Executives
Ke Zhong He Core technical personnel